Esperion Therapeutics (Pharmaceuticals) Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 218
Employees
  • Stock Symbol
  • ESPR
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $6.31
  • (As of Friday Closing)

Esperion Therapeutics (Pharmaceuticals) General Information

Description

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Contact Information

Formerly Known As
HDL Therapeutics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 3891 Ranchero Drive
  • Suite 150
  • Ann Arbor, MI 48108
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperion Therapeutics (Pharmaceuticals) Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.31 $6.18 $3.28 - $26.77 $389M 63M 1.41M -$6.99

Esperion Therapeutics (Pharmaceuticals) Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 292,355 484,126 515,780 1,386,759
Revenue 89,305 78,447 227,547 148,364
EBITDA (182,002) (222,143) (120,334) (88,726)
Net Income (234,904) (269,108) (143,551) (97,165)
Total Assets 342,853 381,590 353,258 214,447
Total Debt 260,158 260,196 185,408 1,563
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Esperion Therapeutics (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Esperion Therapeutics (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Esperion Therapeutics (Pharmaceuticals) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Esperion Therapeutics (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Esperion Therapeutics (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies f
Pharmaceuticals
Ann Arbor, MI
218 As of 2021
00000
00000000000 00000

0000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
000000000000000
Menlo Park, CA
000 As of 0000
00000
00000000000 00000

00000000

t. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pari
0000 00000000
Malvern, PA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Esperion Therapeutics (Pharmaceuticals) Competitors (44)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corcept Therapeutics Formerly VC-backed Menlo Park, CA 000 00000 00000000000 00000
00000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
00000000 000000000 Corporation West Conshohocken, PA 00 000.00 000000 - 000 000.00
000000000 00000000 Formerly VC-backed Tarrytown, NY 00000 00000 00000000000 00000
0000000 000000 Formerly VC-backed Balma, France 00 00000 000000000 00000
You’re viewing 5 of 44 competitors. Get the full list »

Esperion Therapeutics (Pharmaceuticals) Patents

Esperion Therapeutics (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210139401-A1 Methods of making bempedoic acid and compositions of the same Pending 21-Jun-2019 0000000000
US-20210139405-A1 Methods of making bempedoic acid and compositions of the same Pending 21-Jun-2019 0000000000
US-20210322375-A1 Combination drug formulations for treating patients with cardiovascular disease and associated conditions Pending 27-Aug-2018 0000000000
EP-3844168-A1 Combination drug formulations for treating patients with cardiovascular disease and associated conditions Pending 27-Aug-2018 0000000000
AU-2019325705-A1 Methods for reducing the risk of diabetes in patients being treated for high cholesterol-related illnesses Pending 24-Aug-2018 A61K31/194
To view Esperion Therapeutics (Pharmaceuticals)’s complete patent history, request access »

Esperion Therapeutics (Pharmaceuticals) Executive Team (16)

Name Title Board Seat Contact Info
Sheldon Koenig Chief Executive Officer & Board Member
Rick Bartram Chief Financial Officer
Ken Fiorelli Ph.D Chief Technical Operations Officer
Marianne Andreach Senior Vice President, Product Planning
JoAnne Foody Chief Medical Officer
You’re viewing 5 of 16 executive team members. Get the full list »

Esperion Therapeutics (Pharmaceuticals) Board Members (19)

Name Representing Role Since
Alan Fuhrman Self Board Member 000 0000
Antonio Gotto Jr. Self Board Member 000 0000
Dov Goldstein MD Aisling Capital Board Member 000 0000
Jay Shepard Self Board Member 000 0000
Jeffrey Berkowitz JD Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Esperion Therapeutics (Pharmaceuticals) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Esperion Therapeutics (Pharmaceuticals) Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 28-Apr-2008 0000000000 000 Drug Discovery
Talaria Therapeutics 05-Oct-2000 Merger/Acquisition 00.00 Drug Discovery
To view Esperion Therapeutics (Pharmaceuticals)’s complete acquisitions history, request access »